This is actually a positive sign, since platforms that approve everyone regardless of medical history are cutting corners on safety
Pregnancy and Lactation: Recognizing the lack of comprehensive studies on semaglutides effects during pregnancy and breastfeeding, we advise against its use to safeguard maternal and infant health
GLP-1 receptor agonists are prescribed to manage type 2 diabetes by regulating blood sugar and, in some cases, to support weight loss
Listed Products of GLP-1 Receptor Agonists (GLP-1RA) At present, 9 GLP-1 receptor agonist hypoglycemic drugs have been approved for marketing in the world, namely: exenatide, liraglutide, Exenatide extended-release (exenatide ER), albiglutide, dulaglutide , lixisenatide, benaglutide, semaglutide, polyethylene glycol loxenatide injection and oral semaglutide